January 10, 2019
After a serious bike crash, Nina Dang received an emergency department (ED) bill for more than $24,000, of which her insurer covered only $3,800, because the ED was not in Dang's insurance plan network—or in any private insurance network at all.
Eli Lilly has become the first drugmaker to begin complying with an initiative Pharmaceutical Research and Manufacturers of America announced last year, under which its members will direct consumers to company websites with pricing information for their products.
A patient and his wife were not seeking a diagnosis when they came to Lisa Sanders; they wanted to know why, despite scores of doctor visits and treatments, the patient was still experiencing symptoms—and the final answer was not what they expected.
The Supreme Court on Monday heard oral arguments in a case centered on whether a drugmaker is liable under state law for drug-related injuries when FDA denies the drugmaker's request to revise a product's warning label.
January 9, 2019
From influenza facts to buzzing diets to women's health concerns, CNN rounds up the 10 most-Googled health questions of 2018.
Democratic governors in California and Washington and New York City's mayor over the past few days have unveiled proposals to significantly expand public health programs, including some proposals that would offer residents universal coverage.
Chris Traylor, who previously served as CMS' deputy administrator for strategic initiatives, will assume the role of acting director of the Center for Medicaid and CHIP, replacing Mary Mayhew, who resigned from the post last week.
Prescription drug costs in the United States continue to rise each year, and while there has been some debate as to what is driving those increases, a new study suggests there are two key factors that influence the market in different ways.
Pedialyte started as an over-the-counter drink aimed at rehydrating children, but the brand recently set its sights on adult sales in a successful marketing shift targeting hangovers that sheds light on the overlap between a consumer culture of so-called "social media influencers" and medicine.
Maddie Linsenmeir died last fall of an opioid overdose, and her family chose to share her much-read story so others dealing with substance use disorders know "every breath is a fresh start," and to encourage individuals "reading [the obituary] with judgment" to "educate [themselves] about this disease, because that is what it is. It is not a choice or a weakness."
The Advisory Board Company. All Rights Reserved.